Get the Stockscreener App
137.71
0.17%
-0.09
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Citigroup Inc stock is traded at $137.71, with a volume of 3.13M.
It is down -0.17% in the last 24 hours and up +1.73% over the past month.
Citigroup is a global financial powerhouse that orchestrates the movement of $5 trillion in daily transaction volume, serving as the essential connective tissue for the world's most complex multinational corporations. The firm remains a leader on the global stage, servicing 90% of the Fortune 500 through a proprietary network that includes direct membership to over 270 cash-clearing centers and a footprint that spans 94 countries. After a checkered history operating as an overly complex, disjointed firm, steps have been taken to streamline operations, resulting in organization across five segments: services, markets, banking, wealth, and US personal banking.
See More
Previous Close:
$137.80
Open:
$137.55
24h Volume:
3.13M
Relative Volume:
0.29
Market Cap:
$230.98B
Revenue:
$175.96B
Net Income/Loss:
$18.10B
P/E Ratio:
14.87
EPS:
9.2638
Net Cash Flow:
$38.28B
1W Performance:
-0.42%
1M Performance:
+1.73%
6M Performance:
+26.24%
1Y Performance:
+41.57%
1-Day Range:
$136.57
$138.85
1-Week Range:
$133.87
$138.85
52-Week Range:
$93.66
$147.96
Citigroup Inc Stock (C) Company Profile
Name
Citigroup Inc
Sector
Industry
Phone
(212) 559-1000
Address
388 GREENWICH STREET, NEW YORK, NY
Compare C vs JPM, BAC, HSBC, RY, WFC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
C
Citigroup Inc
|
137.70 | 231.15B | 175.96B | 18.10B | 38.28B | 9.2638 |
JPM
Jpmorgan Chase Co
|
352.52 | 942.89B | 297.42B | 64.78B | 148.32B | 23.34 |
BAC
Bank Of America Corp
|
62.26 | 438.24B | 194.43B | 33.77B | 64.54B | 4.3483 |
HSBC
Hsbc Holdings Plc Adr
|
103.61 | 359.98B | 133.80B | 21.76B | 105.99B | 6.0511 |
RY
Royal Bank Of Canada
|
205.81 | 286.31B | 99.69B | 16.04B | 26.84B | 11.15 |
WFC
Wells Fargo Co
|
88.84 | 271.16B | 128.92B | 22.97B | -2.35B | 6.8796 |
Citigroup Inc Stock (C) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-26 | Initiated | Jefferies | Buy |
| Dec-12-25 | Upgrade | JP Morgan | Neutral → Overweight |
| May-15-25 | Initiated | TD Cowen | Hold |
| Jan-06-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-03-24 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Apr-04-24 | Reiterated | Evercore ISI | In-line |
| Mar-25-24 | Reiterated | Wells Fargo | Overweight |
| Mar-14-24 | Upgrade | Goldman | Neutral → Buy |
| Feb-14-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-30-24 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Jan-10-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-09-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-08-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-03-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-18-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Sep-07-23 | Initiated | HSBC Securities | Hold |
| Jul-18-23 | Upgrade | Odeon | Hold → Buy |
| Jul-10-23 | Downgrade | Societe Generale | Buy → Hold |
| Dec-08-22 | Initiated | Piper Sandler | Neutral |
| Oct-03-22 | Downgrade | Goldman | Buy → Neutral |
| Sep-06-22 | Downgrade | Odeon | Buy → Hold |
| May-27-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-28-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Mar-07-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-03-22 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Dec-15-21 | Upgrade | Odeon | Hold → Buy |
| Dec-10-21 | Resumed | UBS | Neutral |
| Dec-06-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-21 | Resumed | Keefe Bruyette | Outperform |
| Jun-16-21 | Reiterated | Credit Suisse | Outperform |
| Apr-05-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-29-21 | Downgrade | Edward Jones | Buy → Hold |
| Jan-21-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-06-21 | Initiated | Daiwa Securities | Buy |
| Jan-04-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Nov-19-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Oct-15-20 | Downgrade | DZ Bank | Buy → Hold |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-18-20 | Downgrade | Odeon | Hold → Sell |
| Jul-17-20 | Downgrade | Odeon | Buy → Hold |
| Jul-08-20 | Initiated | Seaport Global Securities | Buy |
| Jul-07-20 | Upgrade | Societe Generale | Hold → Buy |
| Jun-09-20 | Downgrade | Standpoint Research | Buy → Hold |
| Jun-02-20 | Upgrade | Odeon | Hold → Buy |
| May-18-20 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-20-20 | Upgrade | Argus | Hold → Buy |
| Apr-14-20 | Upgrade | Societe Generale | Sell → Hold |
| Apr-01-20 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Feb-03-20 | Downgrade | Odeon | Buy → Hold |
| Jan-09-20 | Initiated | DA Davidson | Buy |
| Jan-06-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-20 | Reiterated | Goldman | Buy |
| Jul-26-19 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| May-30-19 | Upgrade | Goldman | Neutral → Buy |
| Feb-22-19 | Upgrade | Jefferies | Hold → Buy |
View All
Citigroup Inc Stock (C) Latest News
Acumen at Citi biopharma summit: bets on oligomers and brain delivery - Investing.com
Citigroup Inc. stock gains as recent earnings beat expectations - ad-hoc-news.de
Why Is Citigroup (NYES:C) Expanding in China Brokerage? - Kalkine Media
Citigroup (C) Gains on Turnaround Momentum - Yahoo Finance
4 Thriving Investment Bank Behemoths to Buy With Attractive Valuation - TradingView
Form 8K Citigroup For: 10 September By Investing.com - Investing.com UK
Citigroup Upgrades UiPath (NYSE:PATH) to "Strong-Buy" - MarketBeat
Nordnet AB And Citigroup Inc. Launch Research Portal Giving Savers Access To Research - marketscreener.com
Citigroup Inc. $C Shares Acquired by Tidal Investments LLC - MarketBeat
Citigroup Adjusts Price Target on Boston Scientific to $57 From $61, Keeps Buy Rating - marketscreener.com
Citigroup Inc. $C Position Trimmed by National Pension Service - MarketBeat
WINTON GROUP Ltd Has $11.44 Million Holdings in Citigroup Inc. $C - MarketBeat
Engineers Gate Manager LP Lowers Stake in Citigroup Inc. $C - MarketBeat
BlueCrest Capital Management Ltd Reduces Holdings in Citigroup Inc. $C - MarketBeat
Citigroup stock heads into the open after a 1.0 percent gain - ad-hoc-news.de
Citigroup Becomes Substantial Shareholder in Lotus Resources with 5.08% Stake - Kalkine
BioAge at Citi biopharma summit: pivot to eye disease and new targets - Investing.com Canada
Citigroup's Private Bank Hires Radzinski From Bank Of America - marketscreener.com
Veradermics at citigroup summit: oral hair-loss drug nears key data - Investing.com
Citi Private Bank hires Radzinski from Bank of America - WTVB
Akamai Technologies Jumps 5.3% After Citigroup Maintains Neutral - news.alphastreet.com
Transcript : Cytokinetics, Incorporated Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 03:00 PM - marketscreener.com
Beam Therapeutics at Citi summit: platform gains momentum across pipeline By Investing.com - Investing.com Canada
Citigroup : Citi First Quarter, Second Quarter, Third Quarter and Fourth Quarter 2027 Earnings Calls - marketscreener.com
LULU Maintained by Citigroup -- Price Target Lowered to $117.00 - GuruFocus
Cytokinetics at citigroup summit: hcm expansion drives growth hopes By Investing.com - Investing.com India
Transcript : Protagonist Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 10 - marketscreener.com
Transcript : Beam Therapeutics Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 01 - marketscreener.com
Lexicon Pharmaceuticals at Citi summit: hcm data, t1d reset - Investing.com
Transcript : Spyre Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 10 - marketscreener.com
Ollie’s Bargain Outlet Holdings Drops 5.7% After Citigroup Maintains Buy - news.alphastreet.com
Learn Why The Bull Case For Citi Stock Could Change Following China Brokerage Approval - simplywall.st
Transcript : BioAge Labs, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 11 - marketscreener.com
Vor Biopharma at Citigroup’s biopharma back to school summit: pipeline push By Investing.com - Investing.com Canada
Nuvation Bio at citigroup biopharma summit: growth rests on three pillars - Investing.com India
Lexicon Pharmaceuticals at Citi summit: hcm data, t1d reset By Investing.com - Investing.com UK
Transcript : Celcuity Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 08 - marketscreener.com
Transcript : Allogene Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 08 - marketscreener.com
Arcus Biosciences at Citi summit: casdatifan data loom large By Investing.com - Investing.com Canada
Transcript : EyePoint, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 08 - marketscreener.com
Arcturus Therapeutics at Citi summit: two catalysts, one pivotal year - Investing.com
Jade Biosciences at citigroup summit: fast-track bet on igan By Investing.com - Investing.com UK
Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating - marketscreener.com
Exelixis at Citigroup summit: building a second growth engine - Investing.com
Is It Worth Investing in Citigroup (C) Based on Wall Street's Bullish Views? - Yahoo Finance
Allogene at Citi summit: mrD strategy and cash runway in focus - Investing.com
EyePoint at Citi summit: wet AMD setback, but path stays open - Investing.com India
Form FWP CITIGROUP INC Filed by: CITIGROUP INC - StreetInsider
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc. - StreetInsider
Capital Analysts LLC Lowers Stock Holdings in Citigroup Inc. $C - MarketBeat
Goldman Sachs Adjusts Price Target on Citigroup to $175 From $161, Keeps Buy Rating - marketscreener.com
Citigroup Inc Stock (C) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):